Previous close | 2.0000 |
Open | 1.9500 |
Bid | 1.0000 |
Ask | 2.2000 |
Strike | 7.50 |
Expiry date | 2024-06-21 |
Day's range | 1.8000 - 2.1400 |
Contract range | N/A |
Volume | |
Open interest | 1.15k |
Verastem (VSTM) gains 57% post-market on achieving a confirmed partial response in 83% of first-line patients treated with novel combo therapy in the initial cohort of its phase I/II pancreatic cancer study.
Bicycle Therapeutics (BCYC) gains 10% upon entering a PIPE financing agreement with multiple institutional investors, which is expected to generate gross proceeds of $555 million.
Deciphera (DCPH) soars 74.3% in the past month on a $2.4 billion buy-out offer from ONO Pharmaceuticals. The transaction is expected to close in the third quarter of 2024.